A draft 02/08/02-25/00154538, which is intended to update a procedure for the establishing and functioning of a medical panel in healthcare organisations (“Draft”), has been placed on the Federal Portal of Draft Regulatory Legal Acts.

On 4 February 2025, the official portal of legal information were posted:

1. Order of the Ministry of Health No. 708n of 23 December 2024 “On Approval of the Procedure for Maintaining the Register of Issued Permits to Conduct Clinical Trials of Pharmaceuticals” (“Order No. 708n”) - the document replaces Order of the Ministry of Health No. 754n dated 26 August 2010;
2. Order of the Ministry of Health No. 706n dated 20 December 2024 establishing the procedure for the Ministry of Health to publish on its website a list of medical organisations conducting clinical trials (“Order No. 706n”) - the document replaces Order of the Ministry of Health No. 752n dated 26 August 2010.

Both documents entered into force on 15 February 2025 and aim to harmonise with the provisions of the EAEU regulations, as well as to simplify the system of information resources maintenance by the Ministry of Health by abolishing the “paper” document flow.

On 19 December 2024, the competent committees of the Federation Council of the Russian Federation approved Bill No. 670471-8 "On Amending the Criminal Code of the Russian Federation (in terms of clarifying liability for certain crimes against minors and against public health)" (hereinafter - the “Bill”).

The new review of the most notable patents disputes in Life Sciences in Russian and the CIS.

• pdf, 2.52 Mb

On December 11, 2024, Moscow hosted XV Indian-Russian Business-Dialogue Forum. Organised by the Indian Business Alliance, the Business Council for Cooperation with India, the Moscow Government, and Roscongress, the event gathered together leading politicians, business leaders, and experts to discuss key economic issues and explore new opportunities for collaboration.

On 5 December 2024 the results of the annual Pravo-300 law firms’ ranking were announced at an awarding ceremony at The Carlton Hotel in Moscow. This year Lidings expertise is highly praised in 17 key practice areas.

On November 22, 2024, the Government of the Russian Federation (the “Government”) approved Resolution No. 1607 dated November 22, 2024 (the “Resolution”) on the experiment in the territory of the Russian Federation to conduct monitoring of Russian manufacturers of goods which are subject to mandatory marking with means of identification using the state information monitoring system for the circulation of goods subject to mandatory marking with means of identification (the “Experiment”).

More in our update.

Lidings’ Intellectual Property practice team succeeded in obtaining cancellation of registration of a drug in a dispute against the holder of the marketing authorisation (MA) due to the fact that during the process of registration of a generic drug product the Ministry of Health of Russia received false information from the holder of the MA.

Senior associate of the Lidings’ Intellectual Property practice Vladislav Ryabov will take part in the International Conference entitled Intellectual Property Right: Challenges of 21st Century. The conference will take place on 14-16 November 2024 at the campus of the National Research Tomsk State University.

On November 7, 2024, Lidings held a round table discussion " Launch of Medicines and Pharmaceutical Substances in Russian and Indian Markets" as part of the business program of the Forum "Under One Sun: Russia-India. Business and Culture ", which took place in Delhi, November 6 - 8, 2024.

Highlights of the event in our overview.